Brian Dow

Brian Dow is an accomplished financial executive with extensive experience serving as Chief Financial Officer at various companies, including SAGA Diagnostics (2025 - Present), ProSomnus® Sleep Technologies (2023 - 2025), and Agendia (2020 - 2023), among others. Dow's career highlights encompass leadership roles at Pulse Biosciences, Progyny, Inc., and Northstar Neuroscience, where responsibilities included overseeing financial operations and corporate governance. Previously held positions as Vice President and Principal Accounting Officer at Pacific Biosciences and corporate controller roles at Radiant Research, Qpass, and Vixel Corporation showcase a robust background in accounting and finance. Brian Dow holds a Bachelor of Science in Management from the Georgia Institute of Technology, completed in 1992.